• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

21/01/2026 15:20

Indo US Bio-Tech Q3 net profit down 40.59% at Rs 3.00 cr

The company reported standalone net profit of Rs 3.00 crore for the quarter ended December 31, 2025 as compared to Rs 5.05 crore in the same period last year, registering a year-on-year decline of 40.59 per cent.

Net revenue of the company declined marginally by 3.23 per cent at Rs 22.80 crore in October-December quarter of this fiscal as against Rs 23.56 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 3.50 per cent to Rs 18.65 crore from Rs 18.02 crore in year ago period.

Other Income dipped by 50.00 per cent at Rs 0.01 crore versus (Dec'24 Rs 0.02 crore).

Operating Profit slipped by 25.09 per cent to Rs 4.15 crore as against Rs 5.54 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 22.59 per cent in December quarter.

Interest grew by 102.63 per cent y-o-y to Rs 0.77 crore, while Taxation increased by 525.00 per cent at Rs 0.17 crore (Dec'24 Rs -0.04 crore).